The impact of anorexigenic peptides in experimental models of Alzheimer's disease pathology.

@article{Maletnsk2018TheIO,
  title={The impact of anorexigenic peptides in experimental models of Alzheimer's disease pathology.},
  author={Lenka Malet{\'i}nsk{\^a} and Andrea Popelov{\'a} and Blanka Železn{\'a} and Michal Bencze and Jaroslav Kune{\vs}},
  journal={The Journal of endocrinology},
  year={2018}
}
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder in the elderly population. Numerous epidemiological and experimental studies have demonstrated that patients who suffer from obesity or type 2 diabetes mellitus have a higher risk of cognitive dysfunction and of AD. Several recent studies demonstrated that food intake-lowering (anorexigenic) peptides have the potential to improve metabolic disorders and that they may also potentially be useful in the treatment of… CONTINUE READING
4
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 247 REFERENCES

The prolactin releasing peptides: RF-amide peptides

  • Cellular and Molecular Life Sciences CMLS
  • 2001
VIEW 19 EXCERPTS
HIGHLY INFLUENTIAL

A talk between fat tissue, gut, pancreas and brain to control body weight

  • Molecular and Cellular Endocrinology
  • 2015
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

DA5-CH, a novel GLP-1/GIP dual agonist, Downloaded from Bioscientifica.com at 01/07/2019 02:47:39PM via free access

Y Cao, C Hölscher, +6 authors JS Qi
  • 2018

Similar Papers

Loading similar papers…